118 results
8-K
EX-10.1
BIOL
Biolase Inc
15 Feb 24
BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
5:15pm
; and to the Company’s knowledge, there are no health care laws which as of this date are material to the business of the Company which is not described
424B1
BIOL
Biolase Inc
14 Feb 24
Prospectus with pricing info
9:21pm
, and results of operations.
We could be subject to or otherwise affected by, federal and state health care laws, including fraud and abuse and health … significant costs and burdens on us, which could increase our operating expenses.
Changes in health care regulations in the U.S. and elsewhere could adversely
D
l8fja8s63u3v
20 Dec 23
$2.73 mm in equity / options / securities to be acquired, sold $2.73 mm, 1 investor
2:13pm
424B1
9obl5m9w4cch 1rm
15 Sep 23
Prospectus with pricing info
5:27pm
424B1
uc025e30aa3 fqc
15 Sep 23
Prospectus with pricing info
5:27pm